IL4 and rheumatoid arthritis: A reduction in disease severity and bone resorption could be caused by the blockage of these molecules [29], whereas IL-4 and IL-10 possess potent antiinflammatory characteristics and can suppress cartilage and bone pathology in patients with RA [30].